OAKLAND, N.J., April 12, 2019 /PRNewswire/ — Collagen Matrix, Inc., a leader in regenerative medicine and a global manufacturer of collagen and mineral based medical devices announced today the FDA 510(k) clearance of its innovative line of Mineral Collagen Composite Bioactive Moldable Bone Graft Matrix through its Spine business unit. OssiMend® Bioactive Moldable Bone Graft Matrix is a …